In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From GIB LLC

FDA Intends To Answer EWG’s Hair-Straightener Petition By End Of March

The agency plans to respond by March 30 to the Environmental Working Group’s 2011 citizen petition requesting regulatory action on hair-straightening products that contain or release formaldehyde. In doing so, it could win dismissal of a related suit filed by the NGO and put marketers on notice about regulatory measures that either are, or are not, coming their way.

Regulation Cosmetics

EWG Lawsuit Slams FDA’s Failure To Act On ‘Formaldehyde-Laced’ Hair Smoothers

The Environmental Working Group seeks decisive FDA action on formaldehyde in heated hair-smoothing products, as requested in its 2011 citizen petition, with a complaint filed in District of Columbia District Court. The suit doubles as a reminder to Congress and consumers that cosmetics regulations are overdue for an update, the NGO says.

Cosmetics Ingredients

Brazilian Blowout Manufacturer Required To Label, Warn Users

Brazilian Blowout parent company GIB LLC has settled a class action suit in California that directs the firm to pay more than $4 million to class members and properly label products with all ingredients and warnings about potential health risks.

Cosmetics Adverse Events Reported To FDA Increase 35% In FY 2012

The number of adverse events associated with cosmetics reported to FDA rose by nearly 100 between fiscal 2011 and 2012. The rise follows a push by the agency to increase awareness of the reporting program, but FDA cautions that may not solely be responsible for the higher numbers.

See All
UsernamePublicRestriction

Register